Education
About Us
Working with TipRanks
Follow Us
Orasure Technologies (OSUR)
NASDAQ:OSUR
Earnings Data
Report Date
May 07, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.2Last Year’s EPS
-0.05Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 25, 2025
|% Change Since: -10.75%
|Next Earnings Date:May 07, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and strategic acquisitions, which are positive indicators. However, external uncertainties such as funding issues and challenges in specific segments present potential risks. The sentiment is balanced between optimistic growth prospects and cautiousness due to external factors.Company Guidance
During the Q4 2024 earnings call, OraSure Technologies provided guidance and updates on their strategic initiatives and financial performance. The company reported total revenue of $37.4 million, with core revenue increasing by 10% year-over-year to $36.5 million. Specifically, diagnostic product sales grew by 9%, generating $18.8 million, while sample management solutions revenue rose by 14% to $14.8 million. The company highlighted notable achievements, including the acquisition of Sherlock Biosciences and FDA approval for expanded use of the OraQuick HIV self-test. Despite facing uncertainties in global markets, OraSure is focused on strategic transformation, aiming for significant gross margin expansion towards 50% in 2025 through operational efficiencies and innovations. For Q1 2025, the company projects total revenue between $27.5 million and $31.5 million. They also emphasized the impact of external factors such as potential reductions in NIH funding and changes to US foreign aid programs, particularly PEPFAR, which could affect their international diagnostics revenue.Revenue Growth
OraSure Technologies reported Q4 revenue of $37.4 million, with core revenue growing 10% year-over-year. Diagnostics revenue increased by 9% and sample management solutions revenue grew by 14%.
Acquisition of Sherlock Biosciences
OraSure acquired Sherlock Biosciences to expand its innovation pipeline with a molecular diagnostic platform. The first molecular self-test for chlamydia and gonorrhea is expected to be submitted to the FDA by end of 2025.
FDA Approval for Expanded HIV Testing
OraSure secured FDA approval to expand the age range for its OraQuick HIV self-test, increasing accessibility to individuals aged 14 and older.
Positive Cash Flow from Operations
The company generated positive cash flow from operations in its core business during Q4, demonstrating progress in operating efficiency and cost savings initiatives.
Strong International Performance
OraSure's international diagnostic business delivered strong performance, with 2024 being a record year for revenue, surpassing the previous high set in 2023.
---
OSUR Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
OSUR Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 25, 2025 | $4.00 | $3.06 | -23.50% |
| Nov 06, 2024 | $4.40 | $4.24 | -3.64% |
| Aug 06, 2024 | $4.32 | $4.34 | +0.46% |
| May 08, 2024 | $5.31 | $5.04 | -5.08% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Orasure Technologies (OSUR) report earnings?
Orasure Technologies (OSUR) is schdueled to report earning on May 07, 2025, TBA Not Confirmed.
What is Orasure Technologies (OSUR) earnings time?
Orasure Technologies (OSUR) earnings time is at May 07, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is OSUR EPS forecast?
OSUR EPS forecast for the fiscal quarter 2025 (Q1) is -0.2.
---